Navigation Links
Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
Date:2/11/2009

e body's major biological functions and physio-pathological processes. The most advanced peptide discovered by Ferring Research Institute, degarelix--an innovative treatment for prostate cancer, was recently approved by the U.S. Food and Drug Administration (FDA) and will be launched in Q1 of 2009 in the U.S. Other peptides discovered by Ferring Research Institute include: barusiban (FE 200440), an oxytocin receptor antagonist; FE 202158, a selective V1a receptor agonist; FE 200665 (a.k.a. CR665), a first generation peripherally-selective kappa opioid receptor agonist; FE 202845 (a.k.a. CR845), a second generation. Long-acting peripherally-selective kappa opioid receptor agonist; and FE 202767, a selective oxytocin receptor agonist. More information is available at www.ferring-research.com.

    For U.S. Media Inquiries:
    Della Sweetman or Jamie Leicht, Fleishman-Hillard, 619.237.7700
    della.sweetman@fleishman.com or jamiemarie.leicht@fleishman.com

    For Global Inquiries:
    Helen Gallagher or Michael George, Ferring Pharmaceuticals
    helen.gallagher@ferring.com or michael.george@ferring.com


'/>"/>
SOURCE Ferring Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... ADELAIDE, Australia , Feb. 27, 2015 ... data from the DisrupTOR-1 trial of BNC105 in patients ... Symposium in Orlando, Florida . The ... of the City of Hope Comprehensive Cancer Center ... presentation. The new data identifies Ferritin ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
(Date:2/27/2015)... 27, 2015  Steep Hill, the industry leader in ... intends to open a full service medical cannabis quality ... , bringing advanced scientific tools and methodology to the ... Hill is currently the only laboratory licensed by the ... contaminant testing in order to meet the recently adopted ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2
... Horizon Therapeutics, Inc., a,privately held biopharmaceutical company, announced ... officer, will present a corporate,overview at the JMP ... October 7 at 9 a.m. ET at the ... Horizon Therapeutics, Inc. is a late-stage biopharmaceutical ...
... N.J., Oct. 1 SyntheMed, Inc. (OTC,Bulletin Board: ... commercialization of anti-adhesion products and other surgical,implants, announced ... of a,private placement in which it received $4.0 ... the issuance to investors of ten million units,at ...
... Halozyme Therapeutics, Inc.,(Nasdaq: HALO ), a ... matrix, today announced that it will,host a Research ... p.m. EDT. A,webcast of the presentations will be ... -- Strategic Company Overview, Jonathan Lim, M.D., ...
Cached Biology Technology:SyntheMed Completes $4.0 Million Equity Placement 2Halozyme Therapeutics to Host Research Day for Investors and Analysts 2
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This report ... Thousands by the following Segments: Face Biometrics, and Voice Biometrics. The ... , Japan , Europe ... & Africa , and Latin ... period 2013 through 2020. Also, a seven-year historic analysis is provided ...
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... the chemical marks littering the DNA inside our cells like ... at a time. But new high-throughput DNA sequencing technology has ... map the precise position of these individual DNA modifications throughout ... effect on the activity of any of Arabidopsis roughly 26,000 ...
... have struggled with plutonium contamination spreading further in groundwater ... and animals. It was known nanometer sized clusters ... had been able to study its structure or find ... Scientists at the U.S. Department of Energys Argonne ...
... scientists have uncovered details about the mechanisms through which ... cells, the researchers have linked ribosomes, the protein-making factories ... aids in the expression of genetic information, to the ... which was led by UW faculty members Brian Kennedy ...
Cached Biology News:Charting the epigenome 2Charting the epigenome 3Scientists discover how nanocluster contaminants increase risk of spreading 2Researchers uncover details about how dietary restriction slows down aging 2Researchers uncover details about how dietary restriction slows down aging 3
... cytoplasmic granules, is a key step ... (e.g. basophils, neutrophils, eosinophils, and mast ... secretory granules contain many proinflammatory mediators ... proteases (Hallgren, 2001). Tryptase, a tetrameric ...
... Custom Processing Service enables scientists who do not ... analysis software to have their biological samples tested ... Its as easy as 1-2-3 Chose ... your samples from the S&S antibody menu. ...
... sensitive nucleic acid gel stain has bright fluorescence ... gels, making it ideal for detecting dsDNA in ... SYBR Green I nucleic gel acid stain ... real-time PCR assays and bandshift assays. One mL ...
... Todays advanced protein cross-linking techniques are defined ... Dr. Shan S. Wong. This valuable hardcover ... schemes and current application references. More than ... protein cross-linking and conjugate preparation from ...
Biology Products: